Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Belgian REAL (BE.REAL) Registry
Sponsor: Novartis Pharmaceuticals
Summary
This is an observational non-interventional study. The visit schedule is according to the routine clinical practice. Only data corresponding to study variables within the specified study period will be collected. The study will recruit patients into one single cohort: Inclisiran in combination with other LLTs. The patients will receive Inclisiran therapy as per the approved label and Belgian reimbursement conditions.
Official title: A Belgian Registry to Evaluate the Real Life Treatment With Inclisiran on Top of Standard of Care Lipid-lowering Therapy in Patients With Atherosclerotic Cardiovascular Disease
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
600
Start Date
2022-04-15
Completion Date
2029-03-30
Last Updated
2026-06-02
Healthy Volunteers
No
Conditions
Interventions
Inclisiran
There is no treatment allocation. Patients administered inclisiran by prescription will be enrolled. The patients will receive inclisiran therapy as per the approved label and Belgian reimbursement conditions.